The New World of Medtech Collaborations – Watershed Developments in IP Valuation, Regulatory and Data Protection that are Reshaping the Deal-Making Landscape in the US, UK and Europe

Leads McDermott’s UK Health and Life Sciences Practice Group  

Advises on global M&A and joint ventures across health services, pharma and life sciences, digital health, and health technologies  

Counsels UK and international clients on NHS and public law procurement, regulatory, and contracting matters, including reimbursement and market access  

Advises strategic and private equity investors on transactions and investments in health and life sciences 

Provides multijurisdictional counsel on IP portfolio strategy, including patent prosecution, transactions, and disputes

Focuses on biomedical engineering and life sciences technologies

Handles transactional IP matters, including transaction structuring; portfolio due diligence; and negotiation of collaboration, license, and joint venture agreements

Supports transatlantic disputes, including US district court cases, PTAB proceedings, reexaminations, EPO oppositions, and UPC litigation